Detection and serial monitoring of cells expressing the epithelial surface molecule EpCAM in peripheral blood of patients with hormone receptor positive breast cancer was used to follow the fate of these cells during endocrine e treatment. The gene discussed is NR4A1; the disease is breast cancer.